Sign in
AGTC Stock Price, Chart, Stats & News
Applied Genetic Technologies Corporation
Save
Applied Genetic Technologies Corporation (AGTC) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
AGTC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -20390.46% |
Pretax margin | -21153.85% |
Net margin | -21976.62% |
Effective tax rate | -3.89% |
ROA | -107.11% |
ROE | -123.91% |
D/E | 0.76x |
Interest coverage ratio | -24.78x |
AGTC valuation
P/E | – |
P/S | – |
P/B | 0.60x |
P/CF | -0.27x |
P/FCF | – |
P/OCF | -0.27x |
PEG | -0.00x |
EV multiple | -0.37x |
About
Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets. These encompass treatments for X-linked retinitis pigmentosa and achromatopsia, both currently undergoing Phase 1/2 clinical trials.
Similar securities
Based on sector and market capitalization
Report issue